Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| GLOW 30 | sun bum llc | Marketed | Feb 9, 2023 | Marketed |
| PREMIUM SUNSCREEN LOTION WITH INSTANT BRONZER BROAD SPECTRUM SPF 15 | sun bum llc | Marketed | Feb 9, 2023 | Marketed |
| JAMP TRAMADOL HCL | Jamp Pharma Corporation | Marketed | Feb 8, 2023 | Marketed |
| ACID CONCENTRATE A1241 | chief medical supplies ltd | Marketed | Feb 7, 2023 | Marketed |
| SITAGLIPTIN-METFORMIN | SIVEM PHARMACEUTICALS ULC | Marketed | Feb 6, 2023 | Marketed |
| KORSUVA | vifor fresenius medical care renal pharma ltd | Marketed | Feb 6, 2023 | Marketed |
| SITAGLIPTIN-METFORMIN | sivem pharmaceuticals ulc | Marketed | Feb 6, 2023 | Marketed |
| SITAGLIPTIN-METFORMIN | sivem pharmaceuticals ulc | Marketed | Feb 6, 2023 | Marketed |
| PRO-SITAGLIPTIN MALATE | PRO DOC LIMITEE | Marketed | Feb 3, 2023 | Marketed |
| AURO-METHOTREXATE | auro pharma inc | Marketed | Feb 2, 2023 | Marketed |
| JAMP SITAGLIPTIN | Jamp Pharma Corporation | Marketed | Feb 2, 2023 | Marketed |
| JAMP SITAGLIPTIN | Jamp Pharma Corporation | Marketed | Feb 2, 2023 | Marketed |
| JAMP SITAGLIPTIN | Jamp Pharma Corporation | Marketed | Feb 2, 2023 | Marketed |
| VIREX PLUS | DIVERSEY INC | Marketed | Feb 1, 2023 | Marketed |
| AG-QUETIAPINE FUMARATE | angita pharma inc. | Marketed | Feb 1, 2023 | Marketed |
| PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | PRO DOC LIMITEE | Marketed | Feb 1, 2023 | Marketed |
| PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | PRO DOC LIMITEE | Marketed | Feb 1, 2023 | Marketed |
| AG-QUETIAPINE FUMARATE | angita pharma inc. | Marketed | Feb 1, 2023 | Marketed |
| ANTI-DANDRUFF ANTIPELLICULAIRE 2 IN 1 | l' oreal canada | Marketed | Feb 1, 2023 | Marketed |
| PRO-SITAGLIPTIN MALATE | PRO DOC LIMITEE | Marketed | Feb 1, 2023 | Marketed |
